The global multiple sclerosis drugs market was valued at USD 22.3 Billion in 2025 and is projected to reach USD 39.7 Billion by the end of 2036, expanding at a CAGR of 5.4% from 2026 to 2036. Mar...
Posted by Mayur on July 21 2026 at 12:54 PM
public
The global Primary Progressive Multiple Sclerosis (PPMS) Treatment Market is poised for substantial expansion over the coming decade, supported by increasing disease prevalence, growing healthcar...
Posted by Mayur on June 25 2026 at 05:09 PM
public
Multiple Sclerosis Drugs Market Overview
Multiple sclerosis (MS) drugs are therapeutic agents used to manage multiple sclerosis, a chronic autoimmune disease that affects the central nervous sys...